Weed (BUDZ) Notes Payables (2010 - 2025)

Weed's (BUDZ) quarterly Notes Payables came in at $348018.0 in Q3 2025, up 9406.09% year-on-year from $3661.0 in Q3 2024, and up 0.74% quarter-over-quarter from $345455.0 in Q2 2025.

Weed (BUDZ) Notes Payables (2010 - 2025) Analysis & Trends

Weed's Notes Payables history runs 12 years deep, the most recent figure standing at $348018.0 for Q3 2025.

  • On a quarterly basis, Notes Payables rose 9406.09% year-over-year to $348018.0 in Q3 2025; TTM through Sep 2025 was $348018.0, a 9406.09% increase from a year earlier, with the FY2024 full-year figure at $423328.0, up 11463.18% from the prior year.
  • Notes Payables grew to $348018.0 in Q3 2025 per BUDZ's latest filing, from $345455.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $897661.0 in Q2 2022 and bottomed at $3661.0 in Q4 2022.
  • The 5-year median for Notes Payables is $75822.0 (2021), against an average of $246495.9.
  • Across the five-year window, Notes Payables slumped 99.59% in 2023 and surged 11463.18% in 2024, its largest moves.
  • Year by year, Notes Payables stood at $65607.0 in 2021, then plunged by 94.42% to $3661.0 in 2022, then changed by 0.0% to $3661.0 in 2023, then jumped by 11463.18% to $423328.0 in 2024, then decreased by 17.79% to $348018.0 in 2025.
  • Per Business Quant, the three latest BUDZ Notes Payables figures stand at $348018.0 (Q3 2025), $345455.0 (Q2 2025), and $340891.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Weed 3.72 Mn 3.72 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 348,018.00
Jun 30, 2025 345,455.00
Mar 31, 2025 340,891.00
Dec 31, 2024 423,328.00
Sep 30, 2024 3,661.00
Jun 30, 2024 3,661.00
Mar 31, 2024 3,661.00
Dec 31, 2023 3,661.00
Sep 30, 2023 3,661.00
Jun 30, 2023 3,661.00
Mar 31, 2023 3,661.00
Dec 31, 2022 3,661.00
Sep 30, 2022 763,454.00
Jun 30, 2022 897,661.00
Mar 31, 2022 802,999.00
Dec 31, 2021 65,607.00
Sep 30, 2021 303,700.00
Jun 30, 2021 75,822.00
Mar 31, 2021 287,200.00
Dec 31, 2020 258,200.00